A primer on health-related quality of life in chronic pain medicine

Anesthesia and Analgesia

Volumn 104, Issue 3, 2007, Pages 703-718

  Vetter, Thomas R ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RILEY HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC PAIN; CLINICAL ASSESSMENT; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; CULTURAL ANTHROPOLOGY; DECISION MAKING; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; PEDIATRICS; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW;

EID: 33847203988     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000255290.64837.61     Document Type: Article

References (169)

1. Turk DC, Okifuji A. Psychological aspects of pain. In: Warfield CA, Bajwa ZH, eds. Principles and practice of pain medicine. New York: McGraw-Hill, 2004:139-56.
2. Owens DK. Spine update. Patient preferences and the development of practice guidelines. Spine 1998;23:1073-9.
3. Barofsky I. Patients' rights, quality of life, and health care system performance. Qual Life Res 2003;12:473-84.
4. Addington-Hall J, Kalra L. Who should measure quality of life? BMJ 2001;322:1417-20.
5. Donaldson MS. Taking stock of health-related quality-of-life measurement in oncology practice in the United States. J Natl Cancer Inst Monogr 2004;33:155-67.
6. Varni JW, Burwinkle TM, Lane MM. Health-related quality of life measurement in pediatric clinical practice: an appraisal and precept for future research and application. Health Qual Life Outcomes 2005;3:34.
7. Hickey A, Barker M, McGee H, O'Boyle C. Measuring health-related quality of life in older patient populations: a review of current approaches. Pharmacoeconomics 2005;23:971-93.
8. Anderson RT, Aaronson NK, Bullinger M, McBee WL. A review of the progress towards developing health-related quality-of-life instruments for international clinical studies and outcomes research. Pharmacoeconomics 1996;10:336-55.
9. World Health Organization. Constitution of the World Health Organization. Basic documents. Geneva, Switzerland: World Health Organization, 1948.
10. Patrick DL, Erickson P. Health status and health policy: quality of life in health care evaluation and resource allocation. New York: Oxford Press, 1993.
11. Mantyselka PT, Turunen JH, Ahonen RS, Kumpusalo EA. Chronic pain and poor self-rated health. JAMA 2003;290:2435-42.
12. Patrick DL. Quality of life and health status: concepts and types of measures. In: Armitagep, ed. Encyclopedia of biostatistics. West Sussex, England: Wiley, 1998:3609-13.
13. Fayers PM, Machin D. Quality of life: assessment, analysis, and interpretation. West Essex, England: Wiley, 2000.
14. Carr AJ, Gibson B, Robinson PG. Measuring quality of life: is quality of life determined by expectations or experience? BMJ 2001;322:1240-3.
15. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993;118:622-9.
16. Nelson EC, Berwick DM. The measurement of health status in clinical practice. Med Care 1989;27:S77-90.
17. Wenger NK, Furberg CD. Cardiovascular disorders. In: Spilker B, ed. Quality of life assessment in clinical trials. New York: Raven, 1990:335-45.
18. Naughton MJ, Shumaker SA. The case for domains of function in quality of life assessment. Qual Life Res 2003;12 (Suppl 1):73-80.
19. Turk DC, Dworkin RH, Allen RR, et al. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain 2003;106:337-45.
20. McDowell I. Measuring health: a guide to rating scales and questionnaires. 3rd ed. Oxford: Oxford University Press, 2006.
21. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
22. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol group. Ann Med 2001;33:337-43.
23. McEwen J, McKenna SP. Nottingham Health Profile. In: Spilker B, ed. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. Philadelphia, PA: Lippincott-Raven, 1993:281-6.
24. Ware J Jr, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-33.
25. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The sickness impact profile: development and final revision of a health status measure. Med Care 1981;19:787-805.
26. Furlong WJ, Feeny DH, Torrance GW, Barr RD. The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Ann Med 2001;33:375-84.
27. The WHQOL Group. The World-Health-Organization quality-of-life assessment (WHQOL) - position paper from the World-Health-Organization. Soc Sci Med 1995;41:1403-9.
28. Nelson EC, Wasson JH, Johnson DJ, Hays RD. Dartmouth COOP functional health assessment charts: brief measures for clinical practice. In: Spilker B, ed. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. Philadelphia, PA: Lippincott-Raven, 1996:161-8.
29. Anderson RT, Aaronson NK, Wilkin D. Critical review of the international assessments of health-related quality of life. Qual Life Res 1993;2:369-95.
30. Kaplan RM, Anderson JP, Ganiats TG. The quality of wellbeing scale: rationale for a single quality of life index. In: Walker SR, Rosser RM, eds. Quality of life assessment: key issues in the 1990s. Boston: Kluwer, 1993:65-95.
31. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002;21:271-92.
32. Varni JW, Burwinkle TM, Seid M, Skarr D. The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambul Pediatr 2003;3:329-41.
33. Landgraf JM, Abetz L, Ware JE. The CHQ: a user's manual. Boston, MA: HealthAct, 1999.
34. Starfield B, Riley AW, Green BF, et al. The adolescent child health and illness profile. A population-based measure of health. Med Care 1995;33:553-66.
35. Ravens-Sieberer U, Bullinger M. Assessing health-related quality of life in chronically ill children with the German KINDL: first psychometric and content analytical results. Qual Life Res 1998;7:399-407.
36. Fekkes M, Theunissen NC, Brugman E, et al. Development and psychometric evaluation of the TAPQOL: a health-related quality of life instrument for 1-5-year-old children. Qual Life Res 2000;9:961-72.
37. Rajmil L, Alonso J, Berra S, et al. Use of a children questionnaire of health-related quality of life (KIDSCREEN) as a measure of needs for health care services. J Adolesc Health 2006;38:511-18.
38. Simeoni MC, Auquier P, Antoniotti S, et al. Validation of a French health-related quality of life instrument for adolescents: the VSP-A. Qual Life Res 2000;9:393-403.
39. Spencer NJ, Coe C. Validation of the Warwick child health and morbidity profile in routine child health surveillance. Child Care Health Dev 2000;26:323-36.
40. Stein RE, Jessop DJ. Functional status II(R). A measure of child health status. Med Care 1990;28:1041-55.
41. Walker DK, Stein RE, Perrin EC, Jessop DJ. Assessing psychosocial adjustment of children with chronic illnesses: a review of the technical properties of PARS III. J Dev Behav Pediatr 1990;11:116-21.
42. Garratt A, Schmidt L, Mackintosh A, Fitzpatrick R. Quality of life measurement: bibliographic study of patient assessed health outcome measures. BMJ 2002;324:1417.
43. Drummond M. Introducing economic and quality of life measurements into clinical studies. Ann Med 2001;33:344-9.
44. Hays RD, Anderson R, Revicki D. Psychometric considerations in evaluating health-related quality of life measures. Qual Life Res 1993;2:441-9.
45. Nunnally JC, Bernstein IH. Psychometric theory. 3rd ed. New York: McGraw-Hill, 1994.
46. Revicki DA, Kaplan RM. Relationship between psychometric and utility-based approaches to the measurement of health-related quality of life. Qual Life Res 1993;2:477-87.
47. McHorney CA. Health status assessment methods for adults: past accomplishments and future challenges. Annu Rev Public Health 1999;20:309-35.
48. McHorney CA. Generic health measurement: past accomplishments and a measurement paradigm for the 21st century. Ann Intern Med 1997;127:743-50.
49. Medical Outcomes Trust. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 2002;11:193-205.
50. Maciejewski M. Generic measures. In: Kane RL, ed. Understanding health care outcomes research. 1st ed. Sudbury, MA: Jones and Bartlett, 2004:19-52.
51. Maciejewski M. Generic measures. In: Kane RL, ed. Understanding health care outcomes research. 2nd ed. Boston: Jones and Bartlett, 2006:123-64.
52. Higginson IJ, Carr AJ. Measuring quality of life: using quality of life measures in the clinical setting. BMJ 2001;322:1297-300.
53. Bottomley A, Flechtner H, Efficace F, et al. Health related quality of life outcomes in cancer clinical trials. Eur J Cancer 2005;41:1697-709.
54. Atherly A. Condition-specific measures. In: Kane RL, ed. Understanding health care outcomes research. 2nd ed. Boston: Jones and Bartlett, 2006:165-83.
55. Lurie J. A review of generic health status measures in patients with low back pain. Spine 2000;25:3125-9.
56. Taylor SJ, Taylor AE, Foy MA, Fogg AJ. Responsiveness of common outcome measures for patients with low back pain. Spine 1999;24:1805-12.
57. Serlin RC, Mendoza TR, Nakamura Y, et al. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 1995;61:277-84.
58. Wang XS, Cleeland CS, Mendoza TR, et al. The effects of pain severity on health-related quality of life: a study of Chinese cancer patients. Cancer 1999;86:1848-55.
59. Jensen MP, Dworkin RH, Gammaitoni AR, et al. Do pain qualities and spatial characteristics make independent contributions to interference with physical and emotional functioning? J Pain 2006;7:644-53.
60. Coons SJ, Rao S, Keininger DL, Hays RD. A comparative review of generic quality-of-life instruments. Pharmacoeconomics 2000;17:13-35.
61. Coons SJ, Shaw JW. Generic adult health status measures. In: Fayers P, Hays R, eds. Assessing quality of life in clinical trials. 2nd ed. New York: Oxford University Press, 2005:325-38.
62. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-item short-form health survey (SF-36). II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247-63.
63. Ware JE, Kosinski M, Dewey JE. How to score version two of the SF-36 health survey. Lincoln, RI: QualityMetric, 2000.
64. Hays RD. Generic versus disease-targeted instruments. In: Fayers P, Hays R, eds. Assessing quality of life in clinical trials. 2nd ed. New York: Oxford University Press, 2005:3-8.
65. Wagner AK, Gandek B, Aaronson NK, et al. Cross-cultural comparisons of the content of SF-36 translations across 10 countries: results from the IQOLA Project. International quality of life assessment. J Clin Epidemiol 1998;51:925-32.
66. Ware JE Jr, Gandek B. Overview of the SF-36 health survey and the international quality of life assessment (IQOLA) project. J Clin Epidemiol 1998;51:903-12.
67. Dworkin RH, Turk DC, Farrar JT, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 2005;113:9-19.
68. Bonomi AE, Shikiar R, Legro MW. Quality-of-life assessment in acute, chronic, and cancer pain: a pharmacist's guide. J Am Pharm Assoc (Wash) 2000;40:402-16.
69. Suarez-Almazor ME, Kendall C, Johnson JA, et al. Use of health status measures in patients with low back pain in clinical settings. Comparison of specific, generic and preference-based instruments. Rheumatology (Oxford) 2000;39:783-90.
70. Davidson M, Keating JL, Eyres S. A low back-specific version of the SF-36 Physical Functioning scale. Spine 2004;29:586-94.
71. Nelson EC, Landgraf JM, Hays RD, et al. The functional status of patients. How can it be measured in physicians' offices? Med Care 1990;28:1111-26.
72. Bronfort G, Bouter LM. Responsiveness of general health status in chronic low back pain: a comparison of the COOP charts and the SF-36. Pain 1999;83:201-9.
73. McEwen J. The Nottingham Health Profile. In: Walker SR, Rosser RM, eds. Quality of life assessment: key issues in the 1990s. Boston: Kluwer, 1993:111-30.
74. Bergner M. Development, testing, and use of the sickness impact profile. In: Walker SR, Rosser RM, eds. Quality of life assessment: key issues in the 1990s. Boston: Kluwer, 1993:95-111.
75. Skevington SM. Advancing cross-cultural research on quality of life: observations drawn from the WHOQOL development. World Health Organisation quality of life assessment. Qual Life Res 2002;11:135-44.
76. Skevington SM, Sartorius N, Amir M. Developing methods for assessing quality of life in different cultural settings. The history of the WHOQOL instruments. Soc Psychiatry Psychiatr Epidemiol 2004;39:1-8.
77. Szabo S. World Health Organisation quality of life assessment instrument. In: Spilker B, ed. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. Philadelphia, PA: Lippincott-Raven, 1996:355-62.
78. The WHQOL Group. The World Health Organization quality of life assessment (WHOQOL): development and general psychometric properties. Soc Sci Med 1998;46:1569-85.
79. Bonomi AE, Patrick DL, Bushnell DM, Martin M. Validation of the United States' version of the World Health Organization quality of life (WHOQOL) instrument. J Clin Epidemiol 2000;53:1-12.
80. Harper A, Power M. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med 1998;28:551-8.
81. Cieza A, Stucki G. Content comparison of health-related quality of life (HRQOL) instruments based on the international classification of functioning, disability and health (ICF). Qual Life Res 2005;14:1225-37.
82. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care 1989;27:S217-32.
83. Deyo RA, Battie M, Beurskens AJ, et al. Outcome measures for low back pain research. A proposal for standardized use. Spine 1998;23:2003-13.
84. Atherly A. Condition-specific measures. In: Kane RL, ed. Understanding health care outcomes research. 1st ed. Boston: Jones and Bartlett, 2004:53-66.
85. Roland M, Morris R. A study of the natural history of low-back pain. II. Development of guidelines for trials of treatment in primary care. Spine 1983;8:145-50.
86. Roland M, Morris R. A study of the natural history of back pain. I. Development of a reliable and sensitive measure of disability in low-back pain. Spine 1983;8:141-4.
87. Resnik L, Dobrykowski E. Outcomes measurement for patients with low back pain. Orthop Nurs 2005;24:14-24.
88. Stratford PW, Binkley JM. Applying the results of self-report measures to individual patients: an example using the Roland-Morris questionnaire. J Orthop Sports Phys Ther 1999;29:232-9.
89. Stratford PW, Binkley J, Solomon P, et al. Defining the minimum level of detectable change for the Roland-Morris questionnaire. Phys Ther 1996;76:359-65.
90. Bellamy N, Buchanan WW, Goldsmith CH, et al. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988;15:1833-40.
91. Dunbar MJ, Robertsson O, Ryd L, Lidgren L. Appropriate questionnaires for knee arthroplasty. Results of a survey of 3600 patients from the Swedish knee arthroplasty registry. J Bone Joint Surg Br 2001;83:339-44.
92. Lingard EA, Katz JN, Wright EA, Sledge CB. Predicting the outcome of total knee arthroplasty. J Bone Joint Surg Am 2004;86-A:2179-86.
93. Brazier JE, Harper R, Munro J, et al. Generic and condition-specific outcome measures for people with osteoarthritis of the knee. Rheumatology (Oxford) 1999;38:870-7.
94. Tosteson AN. Preference-based health outcome measures in low back pain. Spine 2000;25:3161-6.
95. Torrance GW. Utility approach to measuring health-related quality of life. J Chronic Dis 1987;40:593-603.
96. Kaplan RM, Feeny D, Revicki DA. Methods for assessing relative importance in preference based outcome measures. Qual Life Res 1993;2:467-75.
97. Drummond MF, Sculpher MJ, Torrance GW, et al. Methods for economic evaluation of health care programmes. 3rd ed. New York: Oxford University Press, 2005.
98. Brown GC, Brown MM, Sharma S. Evidence-based to value-based medicine. Chicago: AMA Press, 2005.
99. Feeny DH. Preference-based utility measures: utility and quality-adjusted life years. In: Fayers P, Hays R, eds. Assessing quality of life in clinical trials. 2nd ed. New York: Oxford University Press, 2005:406-29.
100. Torrance GW, Thomas WH, Sackett DL. A utility maximization model for evaluation of health care programs. Health Serv Res 1972;7:118-33.
101. Torrance GW. Measurement of health state utilities for economic appraisal. J Health Econ 1986;5:1-30.
102. Froberg DG, Kane RL. Methodology for measuring health-state preferences. II. Scaling methods. J Clin Epidemiol 1989;42:459-71.
103. Bennett KJ, Torrance GW. Measuring health preferences and utilities: rating scales, time trade-off and standard gamble methods. In: Spilker B, ed. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. Philadelphia, PA: Lippincott-Raven, 1996:253-65.
104. Dasbach EJ, Teutsch SM. Quality of life. In Haddix AC, Teutsch SM, Corso PS, eds. Prevention effectiveness: a guide to decision analysis and economic evaluation. 2nd ed. New York: Oxford University Press, 2003:77-91.
105. Muennig P. Designing and conducting cost-effectiveness analyses in medicine and health care. San Francisco, CA: Jossey-Bass, 2002.
106. Woloshin S, Schwartz LM, Moncur M, et al. Assessing values for health: numeracy matters. Med Decis Making 2001;21:382-90.
107. Stiggelbout AM, de Haes JC. Patient preference for cancer therapy: an overview of measurement approaches. J Clin Oncol 2001;19:220-30.
108. Kopec JA, Willison KD. A comparative review of four preference-weighted measures of health-related quality of life. J Clin Epidemiol 2003;56:317-25.
109. Marra CA, Woolcott JC, Kopec JA, et al. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc Sci Med 2005;60:1571-82.
110. Torrance GW. Preferences for health outcomes and cost-utility analysis. Am J Manag Care 1997;3 (Suppl):S8-20.
111. Keeny RK, Riaffa H. Decisions with multiple objectives: preferences and value tradeoffs. 2nd ed. New York: Cambridge University Press, 1993.
112. Torrance G, Furlong W, Feeny D, Boyle M. Multi-attribute preference functions: Health Utilities Index Mark 2. Pharmacoeconomics 1995;7:503-20.
113. Feeny D, Furlong W, Torrance GW, et al. Multiattribute and single-attribute utility functions for the Health Utilities Index Mark 3 system. Med Care 2002;40:113-28.
114. Kaplan RM, Bush JW, Berry CC. Health status index: category rating versus magnitude estimation for measuring levels of well-being. Med Care 1979;17:501-25.
115. Kaplan RM, Anderson JP. The general health policy model: an integrated approach. In: Spilker B, ed. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. Philadelphia, PA: Lippincott-Raven, 1996:309-22.
116. Feeny DH, Torrance GW, Furlong WJ. Health Utilities Index. In: Spilker B, ed. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. Philadelphia, PA: Lippincott-Raven, 1996:239-52.
117. Patrick DL, Starks HE, Cain KC, et al. Measuring preferences for health states worse than death. Med Decis Making 1994;14:9-18.
118. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997;35:1095-108.
119. Kind P. The EuroQol instrument: an index of health-related quality of life. In: Spilker B, ed. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. Philadelphia, PA: Lippincott-Raven, 1996:191-201.
120. Brooks R. EuroQol: the current state of play. Health Policy 1996;37:53-72.
121. Luo N, Johnson JA, Shaw JW, et al. Self-reported health status of the general adult US population as assessed by the EQ-5D and Health Utilities Index. Med Care 2005;43:1078-86.
122. Johnson JA, Luo N, Shaw JW, et al. Valuations of EQ-5D health states: are the United States and United Kingdom different? Med Care 2005;43:221-8.
123. Shaw JW, Johnson JA, Coons SJ. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care 2005;43:203-20.
124. Brazier J, Usherwood T, Harper R, Thomas K. Deriving a preference-based single index from the UK SF-36 health survey. J Clin Epidemiol 1998;51:1115-28.
125. McDonough CM, Grove MR, Tosteson TD, et al. Comparison of EQ-5D, HUI, and SF-36-derived societal health state values among spine patient outcomes research trial (SPORT) participants. Qual Life Res 2005;14:1321-32.
126. Eiser C, Mohay H, Morse R. The measurement of quality of life in young children. Child Care Health Dev 2000;26:401-14.
127. Eiser C, Morse R. Can parents rate their child's health-related quality of life? Results of a systematic review. Qual Life Res 2001;10:347-57.
128. Eiser C, Morse R. The measurement of quality of life in children: past and future perspectives. J Dev Behav Pediatr 2001;22:248-56.
129. Eiser C, Morse R. A review of measures of quality of life for children with chronic illness. Arch Dis Child 2001;84:205-11.
130. Schmidt LJ, Garratt AM, Fitzpatrick R. Child/parent-assessed population health outcome measures: a structured review. Child Care Health Dev 2002;28:227-37.
131. Clarke SA, Eiser C. The measurement of health-related quality of life (QOL) in paediatric clinical trials: a systematic review. Health Qual Life Outcomes 2004;2:66.
132. Matza LS, Swensen AR, Flood EM, et al. Assessment of health-related quality of life in children: a review of conceptual, methodological, and regulatory issues. Value Health 2004;7:79-92.
133. Rajmil L, Herdman M, de Sanmamed MJF, et al. Generic health-related quality of life instruments in children and adolescents: a qualitative analysis of content. J Adolesc Health 2004;34:37-45.
134. Cremeens J, Eiser C, Blades M. Characteristics of health-related self-report measures for children aged three to eight years: a review of the literature. Qual Life Res 2006;15:739-54.
135. Davis E, Waters E, Mackinnon A, et al. Paediatric quality of life instruments: a review of the impact of the conceptual framework on outcomes. Dev Med Child Neurol 2006;48:311-18.
136. De Civita M, Regier D, Alamgir AH, et al. Evaluating health-related quality-of-life studies in paediatric populations: some conceptual, methodological and developmental considerations and recent applications. Pharmacoeconomics 2005;23:659-85.
137. Forrest CB, Shipman SA, Dougherty D, Miller MR. Outcomes research in pediatric settings: recent trends and future directions. Pediatrics 2003;111:171-8.
138. Landgraf JM, Abetz L. Measuring health outcomes in pediatric populations: issues in psychometrics and application. In: Spilker B, ed. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. Philadelphia, PA: Lippincott-Raven, 1996:793-802.
139. Drotar D. Validating measures of pediatric health status, functional status, and health-related quality of life: key methodological challenges and strategies. Ambul Pediatr 2004;4:358-64.
140. Eiser C, Morse R. Quality-of-life measures in chronic diseases of childhood. Health Technol Assess 2001;5:1-157.
141. Theunissen NC, Vogels TG, Koopman HM, et al. The proxy problem: child report versus parent report in health-related quality of life research. Qual Life Res 1998;7:387-97.
142. Riley AW, Forrest CB, Rebok GW, et al. The Child Report Form of the CHIP-child edition: reliability and validity. Med Care 2004;42:221-31.
143. Riley AW, Forrest CB, Starfield B, et al. The Parent Report Form of the CHIP-child edition: reliability and validity. Med Care 2004;42:210-20.
144. Riley AW, Forrest CB, Starfield B, et al. Reliability and validity of the adolescent health profile-types. Med Care 1998;36:1237-48.
145. Forrest CB. Outcomes research on children, adolescents, and their families: directions for future inquiry. Med Care 2004;42:III19-23.
146. Landgraf JM, Abetz L. Functional status and well-being of children representing three cultural groups: initial self-reports using the CHQ-CF-87. Psychol Health 1997;12:839-54.
147. Panepinto JA, O'Mahar KM, DeBaun MR, et al. Health-related quality of life in children with sickle cell disease: child and parent perception. Br J Haematol 2005;130:437-44.
148. Panepinto JA, O'Mahar KM, DeBaun MR, et al. Validity of the child health questionnaire for use in children with sickle cell disease. J Pediatr Hematol Oncol 2004;26:574-8.
149. Waters EB, Salmon LA, Wake M, et al. The health and well-being of adolescents: a school-based population study of the self-report child health questionnaire. J Adolesc Health 2001;29:140-9.
150. Ravens-Sieberer U, Bullinger M. KINDL questionnaire for measuring health-related quality of life in children and adolescents revised version (English manual). Berlin: Robert Koch Institute, 2000.
151. Varni JW, Burwinkle TM, Katz ER. The PedsQL in pediatric cancer pain: a prospective longitudinal analysis of pain and emotional distress. J Dev Behav Pediatr 2004;25:239-46.
152. Sawyer MG, Whitham JN, Roberton DM, et al. The relationship between health-related quality of life, pain and coping strategies in juvenile idiopathic arthritis. Rheumatology (Oxford) 2004;43:325-30.
153. Varni JW, Seid M, Knight TS, et al. The PedsQL 4.0 Generic Core Scales: sensitivity, responsiveness, and impact on clinical decision-making. J Behav Med 2002;25:175-93.
154. Rosenbaum PL, Saigal S. Measuring health-related quality of life in pediatric populations: conceptual issues. In: Spilker B, ed. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. Philadelphia, PA: Lippincott-Raven, 1996:785-91.
155. Petrou S. Methodological issues raised by preference-based approaches to measuring the health status of children. Health Econ 2003;12:697-702.
156. Brunner HI, Maker D, Grundland B, et al. Preference-based measurement of health-related quality of life (HRQL) in children with chronic musculoskeletal disorders (MSKDs). Med Decis Making 2003;23:314-22.
157. Furlong W, Barr RD, Feeny D, Yandow S. Patient-focused measures of functional health status and health-related quality of life in pediatric orthopedics: a case study in measurement selection. Health Qual Life Outcomes 2005;3:3.
158. Feeny D, Furlong W, Barr RD, et al. A comprehensive multi-attribute system for classifying the health status of survivors of childhood cancer. J Clin Oncol 1992;10:923-8.
159. Sloan JA, Cella D, Frost M, et al. Assessing clinical significance in measuring oncology patient quality of life: introduction to the symposium, content overview, and definition of terms. Mayo Clin Proc 2002;77:367-70.
160. Samsa G, Edelman D, Rothman ML, et al. Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics 1999;15:141-55.
161. Guyatt GH, Osoba D, Wu AW, et al. Methods to explain the clinical significance of health status measures. Mayo Clin Proc 2002;77:371-83.
162. Crosby RD, Kolotkin RL, Williams GR. Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol 2003;56:395-407.
163. Symonds T, Berzon R, Marquis P, Rummans TA. The clinical significance of quality-of-life results: practical considerations for specific audiences. Mayo Clin Proc 2002;77:572-83.
164. Osoba D, Rodrigues G, Myles J, et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998;16:139-44.
165. Cohen J. Statistical power analysis for the behavioral science. 2nd ed. Hillsdale, NJ: Erlbaum, 1988.
166. Norman GR, Sridhar FG, Guyatt GH, Walter SD. Relation of distribution- and anchor-based approaches in interpretation of changes in health-related quality of life. Med Care 2001;39:1039-47.
167. Greenhalgh J, Long AF, Flynn R. The use of patient reported outcome measures in routine clinical practice: lack of impact or lack of theory? Soc Sci Med 2005;60:833-43.
168. Greenhalgh J, Meadows K. The effectiveness of the use of patient-based measures of health in routine practice in improving the process and outcomes of patient care: a literature review. J Eval Clin Pract 1999;5:401-16.
169. Suarez-Almazor ME, Conner-Spaddy B, Kendall CJ, et al. Lack of congruence in the ratings of patients' health status by patients and their physicians. Med Decis Making 2001;21:113-21.